The new therapy has produced dramatic responses in some men with aggressive prostate cancer and who have failed current therapies.
The new therapy has produced dramatic responses in some men with aggressive prostate cancer and who have failed current therapies.
Prostate cancer is the most common cancer in Australian men, causing the deaths of more than 3,000 men a year. This new understanding may help increase the accuracy of prostate cancer diagnosis in the future. The study, led by Professor Susan Clark and Dr Ruth Pidsley from the Garvan Institute and Professor Gail Risbridger and […]
From the 1980s, when prostate screening became available, many men over 40 were diagnosed with early stage prostate cancer even though they may not have had any symptoms.
Researchers have mapped the entire genome of a prostate tumour, revealing previously undetected levels of DNA rearrangements.
A research technique that is widely used to test new anti-cancer agents could be improved by adoption of a worldwide ‘gold standard’.
A closer look at the cancer figures in relation to age at diagnosis shows a clear and dramatic increase in cancer as we age.
A team of researchers have uncovered new insights into how to prolong the lifespan of the body’s disease-fighting natural killer (NK) cells.
New research has revealed why men with a family history of prostate cancer, and who also carry the BRCA2 gene fault, have a more aggressive form of prostate cancer.
One reason may be that men tend to wait a long time before making a visit to the clinic when they feel unwell compared to women.